Clinical Trial Update: A Clinical Evaluation of the OrSense Non-invasive Blood Hb/Hct Measurement Instrument, the Hemo-Monitor NBM200/MP

View source ↗

Summary

This document reports an update on a clinical evaluation of OrSense's non-invasive blood Hb/Hct measurement device, the Hemo-Monitor NBM200/MP, for anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Hemo-Monitor NBM200/MP

Snippet

Sponsor: OrSense, Ltd. | Conditions: Anemia | Status: UNKNOWN